Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

ClinicalTrials.gov ID: NCT05937854

Public ClinicalTrials.gov record NCT05937854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of PDE5 Inhibitor on Respiratory Symptoms in COPD Complicated by Pulmonary Hypertension

Study identification

NCT ID
NCT05937854
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
VA Office of Research and Development
Federal
Enrollment
126 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Tadalafil Drug

Drug

Eligibility (public fields only)

Age range
35 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2024
Primary completion
Feb 28, 2029
Completion
Feb 28, 2029
Last update posted
May 14, 2026

2024 – 2029

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora Colorado 80045 Recruiting
Atlanta VA Medical and Rehab Center, Decatur, GA Decatur Georgia 30033-4004 Recruiting
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston Massachusetts 02130-4817 Recruiting
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE Omaha Nebraska 68105-1850 Recruiting
Providence VA Medical Center, Providence, RI Providence Rhode Island 02908-4734 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05937854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05937854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →